Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06476145 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Study acronym: ERADICATE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 5, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 8, 2025 to May 30, 2026
    • Study completion date: Mar 8, 2026 to Jan 8, 2027
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AdventHealth
31 trials monitored
See 2 trials at risk
Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)
Trial Details
NCT Number NCT06476145
Lead Sponsor AdventHealth
Collaborators: Northwestern University, White River Junction Veterans Affairs Medical Center, Rush University, University Medical Centre Ljubljana, University of Kansas, Henry Ford Health System, Carilion Clinic, St. Paul's Hospital, Canada, Minneapolis Veterans Affairs Medical Center
Conditions
(from sponsor)		 Adenoma Colon Polyp
Enrollment 342 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov